Zerostack Corp. current report, 05 July 2023

Business Context and Reporting Period

Flora Growth Corp., an Ontario corporation, filed this Form 8-K on July 11, 2023, regarding events beginning July 5, 2023. The filing concerns the proposed sale of its Colombian subsidiaries and related Colombian operating assets. The filing identifies the registrant as Flora Growth Corp., not Zerostack Corp.

Material Transaction and Key Financial Terms

  • On July 5, 2023, Flora entered into a Share Purchase Agreement with Lisan Farma Colombia LLC.
  • Flora agreed to sell all of its shares in five Colombian entities and other assets related to its Colombian operations for CAD $800,000.
  • The assets include the leasehold rights to the 361-acre Cosechemos farm in Giron, Colombia, including 249 licensed cultivation acres, a processing facility, equipment, structures, and cannabis inventory.
  • The transaction also includes equipment, licenses, contracts, and certifications relating to Flora Lab 2 and Flora Lab 4 in Bogota, as well as inventory and accounts receivable associated with Flora’s food and beverage and laboratory businesses.
  • The assets are expected to be transferred on an “as is where is” basis no later than 30 days after closing.

Changes Versus the Prior Comparable Period

The filing does not provide comparative-period revenue, earnings, cash flow, margin, debt, liquidity, or balance-sheet information. The proposed transaction would materially reduce Flora’s Colombian operating footprint, but the filing does not quantify the expected accounting gain or loss, asset carrying values, or impact on future financial statements.

Guidance, Outlook, Risks, and Contingencies

  • Amendment No. 1, effective July 7, 2023, clarified the subsidiaries being sold, changed the proposed closing date to July 12, 2023, and established closing mechanics and deliverables.
  • Flora expected to receive the CAD $800,000 purchase price at closing and transfer the applicable Colombian entities’ shares to Lisan.
  • The filing describes the transaction as expected to close; it does not state that closing had occurred as of the filing date.
  • Completion remains subject to the transaction’s closing conditions and required deliverables, which are not fully detailed in the filing summary.
  • The filing provides no broader financial guidance or management forecast.

Investor Verification Items

  • Verify whether the transaction closed on or about July 12, 2023 and whether Flora received the full CAD $800,000 purchase price.
  • Review the full Share Purchase Agreement and Amendment No. 1 for closing conditions, representations, indemnities, liabilities, and post-closing obligations.
  • Assess the carrying value of the divested Colombian assets and any resulting gain, loss, impairment, or discontinued-operations accounting.
  • Determine the effect of the divestiture on Flora’s revenue, operating expenses, liquidity, cultivation capacity, inventory, and accounts receivable.
  • Confirm the timing and completeness of the transfer of assets required within 30 days after closing.